Indiva (TSXV:NDVA.H) - Aandelenkoers, Nieuws & Analyse

NDVA.H Overzicht aandelen

Engages in the production, processing, and sale of cannabis and cannabis related products in Canada.

NDVA.H fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	1/6
Dividenden	0/6

Beloningen

De winst is de afgelopen 5 jaar met 6.8% per jaar gegroeid

Risicoanalyse

Aandelen zijn zeer illiquide

Heeft minder dan 1 jaar cash runway

Heeft geen betekenisvolle marktkapitalisatie ( CA$6M )

Negatief eigen vermogen

+ 1 meer risico

Indiva Limited Concurrenten

Delivra Health Brands

TSXV:DHB

CA$6.3m

IM Cannabis

CNSX:IMCC

CA$6.5m

1933 Industries

CNSX:TGIF

CA$4.9m

StateHouse Holdings

CNSX:STHZ

CA$7.7m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Indiva
Historische aandelenkoersen
Huidige aandelenkoers	CA$0.03
52 Week Hoogtepunt	CA$0.13
52 Week Laag	CA$0.03
Bèta	1.08
11 maand verandering	0%
3 maanden verandering	-14.29%
1 Jaar Verandering	-45.45%
33 jaar verandering	-93.75%
5 jaar verandering	-90.63%
Verandering sinds IPO	-97.60%

Recent nieuws en updates

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

May 28

Recent updates

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

May 28

Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Sep 29

Rendement voor aandeelhouders

	NDVA.H	CA Pharmaceuticals	CA Markt
7D	0%	-7.1%	-1.1%
1Y	-45.5%	17.1%	20.8%

Rendement versus industrie: NDVA.H presteerde slechter dan de Canadian Pharmaceuticals -sector, die het afgelopen jaar een rendement van 17.1 % opleverde.

Rendement versus markt: NDVA.H presteerde slechter dan Canadian Market, dat het afgelopen jaar een rendement van 20.8 % opleverde.

Prijsvolatiliteit

Is NDVA.H's price volatile compared to industry and market?
NDVA.H volatility
NDVA.H Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.5%
10% least volatile stocks in CA Market	2.9%

Stabiele aandelenkoers: De aandelenkoers van NDVA.H is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: Onvoldoende gegevens om de volatiliteitsverandering van NDVA.H in het afgelopen jaar te bepalen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
n/a	n/a	Niel Marotta	www.indiva.com

Indiva Limited Samenvatting

Hoe verhouden de winst en inkomsten van Indiva zich tot de beurswaarde?
NDVA.H fundamentele statistieken
Marktkapitalisatie	CA$5.86m
Inkomsten(TTM)	-CA$4.44m
Inkomsten(TTM)	CA$37.49m

0.2x

P/S-verhouding

-1.3x

Koers/Winstverhouding

Is NDVA.H overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
NDVA.H resultatenrekening (TTM)
Inkomsten	CA$37.49m
Kosten van inkomsten	CA$26.54m
Brutowinst	CA$10.95m
Overige uitgaven	CA$15.39m
Inkomsten	-CA$4.44m

Laatst gerapporteerde inkomsten

Mar 31, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.023
Brutomarge	29.21%
Nettowinstmarge	-11.83%
Schuld/Eigen Vermogen Verhouding	-1,692.6%

Hoe presteerde NDVA.H op de lange termijn?

Bekijk historische prestaties en vergelijking

NDVA.H Overzicht aandelen

Beloningen

Risicoanalyse

Indiva Limited Concurrenten

TSXV:DHB

CA$6.3m

CNSX:IMCC

CA$6.5m

CNSX:TGIF

CA$4.9m

CNSX:STHZ

CA$7.7m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Insufficient new directors

Indiva Limited Announces Resignation of Rachel Goldman from the Board

New major risk - Financial position

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

Indiva Limited Provides Earnings Guidance for the Second Quarter of 2024

Indiva Limited to Report Q1, 2024 Results on May 23, 2024

Recent updates

Insufficient new directors

Indiva Limited Announces Resignation of Rachel Goldman from the Board

New major risk - Financial position

Indiva Limited's (CVE:NDVA) Subdued P/S Might Signal An Opportunity

Indiva Limited Provides Earnings Guidance for the Second Quarter of 2024

Indiva Limited to Report Q1, 2024 Results on May 23, 2024

Indiva Limited Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

New major risk - Negative shareholders equity

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Indiva Limited to Report Q4, 2023 Results on Apr 25, 2024

New major risk - Market cap size

Insufficient new directors

Indiva Limited announced that it expects to receive CAD 4.312 million in funding

Indiva Limited announced that it expects to receive CAD 4 million in funding

Price target increased by 15% to CA$0.15

Indiva Limited Provides Revenue Guidance for Fourth Quarter of 2023

Third quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.018 loss in 3Q 2022)

Indiva Limited to Report Q3, 2023 Results on Nov 21, 2023

Indiva Limited (CVE:NDVA) Stock Catapults 33% Though Its Price And Business Still Lag The Industry

Is Indiva (CVE:NDVA) Using Debt In A Risky Way?

Second quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.017 loss in 2Q 2022)

Indiva Limited to Report Q2, 2023 Results on Aug 29, 2023

Indiva Limited Launches No Future Gummies and Vapes

New minor risk - Shareholder dilution

New major risk - Share price stability

Indiva Limited announced that it expects to receive CAD 2.155617 million in funding from Canopy Growth Corporation

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2023

Indiva Limited, Annual General Meeting, Jul 18, 2023

Indiva Limited to Report Q1, 2023 Results on May 16, 2023

Is Indiva (CVE:NDVA) A Risky Investment?

Full year 2022 earnings: EPS and revenues miss analyst expectations

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to CA$0.50

Indiva Limited to Report Q3, 2022 Results on Nov 22, 2022

Indiva Limited Provides Revenue Guidance for the Second Half and Full Year of 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Indiva Limited to Report Q2, 2022 Results on Aug 16, 2022

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022

Consensus estimates of losses per share improve by 62%

Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022

Indiva Limited to Report Q1, 2022 Results on May 19, 2022

Price target decreased to CA$0.60

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Indiva Limited Provides Net Revenue Guidance for the First Quarter of 2022

Indiva Limited, Annual General Meeting, Jun 23, 2022

Indiva Limited to Report Fiscal Year 2021 Results on Apr 26, 2022

Is Indiva (CVE:NDVA) Using Too Much Debt?

Indiva Limited Launches New Cannabis Edible Designed for MicroDosing

Indiva Launches New Cannabis Edible Formulated for Night-Time Use

Third quarter 2021 earnings released: CA$0.047 loss per share (vs CA$0.035 loss in 3Q 2020)

Would Indiva (CVE:NDVA) Be Better Off With Less Debt?

Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.029 loss in 2Q 2020)

Indiva Limited Provides Revenue Guidance for the Second Half of 2021

First quarter 2021 earnings released: CA$0.025 loss per share (vs CA$0.029 loss in 1Q 2020)

Full year 2020 earnings released: CA$0.16 loss per share (vs CA$0.14 loss in FY 2019)

Indiva Limited to Introduce Two New Bhang Chocolate Flavours Nationally in Second Quarter of 2021

Indiva Limited Ships Wana Quick Gummies

Indiva Limited Appoints Russell Wilson to the Board of Directors

Indiva Limited announced that it has received CAD 11 million in funding from Sundial Growers Inc.